1. First‐in‐human study assessing safety, tolerability and pharmacokinetics of BI 409306, a selective phosphodiesterase 9A inhibitor, in healthy males. (22nd August 2016) Authors: Moschetti, Viktoria; Boland, Katja; Feifel, Ulrich; Hoch, Anja; Zimdahl‐Gelling, Heike; Sand, Michael Journal: British journal of clinical pharmacology Issue: Volume 82:Number 5(2016:Nov.) Page Start: 1315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗